The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 21, 2024

Filed:

Oct. 06, 2021
Applicant:

Entrada Therapeutics, Inc., Boston, MA (US);

Inventors:

Natarajan Sethuraman, Boston, MA (US);

Jason Ruth, Boston, MA (US);

Louis A. Tartaglia, Boston, MA (US);

Dehua Pei, Columbus, OH (US);

Ziqing Qian, Boston, MA (US);

Assignee:

Entrada Therapeutics, Inc., Boston, MA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 9/00 (2006.01); A61K 38/45 (2006.01); A61K 47/60 (2017.01); C07K 7/64 (2006.01); C12N 9/10 (2006.01);
U.S. Cl.
CPC ...
C12N 9/1077 (2013.01); A61K 38/45 (2013.01); A61K 47/60 (2017.08); C07K 7/64 (2013.01); C12Y 204/02004 (2013.01); C07K 2319/00 (2013.01);
Abstract

Disclosed herein are compositions and methods of treating disclosure provides for compounds for use in treating Mitochondrial Neurogastrointestinal Encephalopathy Syndrome (MNGIE). In some embodiments, the compounds have cell penetrating activity and thymidine phosphorylase activity. In certain embodiments, the compounds disclosed herein comprise: a) at least one cell-penetrating peptide (CPP) moiety; and b) a thymidine phosphorylase, or an active fragment or analog thereof (TP), wherein the CPP is coupled, directly or indirectly, to TP.


Find Patent Forward Citations

Loading…